RxSight, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-12.1M | $-15.9M | $-9.2M | $-9.8M | $-11.8M | $-8.2M | $-5.9M | $-6.3M |
| Depreciation & Amortization | $999.0K | $834.0K | $851.0K | $854.0K | $785.0K | $776.0K | $515.0K | $1.1M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $7.5M | $7.9M | $7.8M | $8.1M | $8.5M | $7.1M | $7.3M | $6.6M |
| Net Cash from Operating Activities | $-9.5M | $-10.9M | $-1.1M | $-1.2M | $-4.4M | $-8.8M | $-4.3M | $650.0K |
| Investing Activities | ||||||||
| Capital Expenditures | $2.0M | $759.0K | $1.1M | $581.0K | $1.5M | $575.0K | $847.0K | $1.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $4.7M | $8.8M | $-9.6M | $-9.0M | $14.7M | $20.9M | $1.3M | $-9.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $662.0K | $-336.0K | $1.1M | $-530.0K | $2.1M | $-735.0K | $3.0M | $878.0K |
| Net Change in Cash | $-4.2M | $-2.4M | $-9.7M | $-10.7M | $12.4M | $11.3M | $24.0K | $-7.7M |
| Free Cash Flow | $-11.5M | $-11.7M | $-2.3M | $-1.8M | $-5.9M | $-9.4M | $-5.1M | $-453.0K |